Xingju Nie1,2, Maria Fatima Falangola1,2, Emilie T. McKinnon1,2,3, Joseph A. Helpern1,2,3, and Jens H. Jensen1,2
1Department of Neuroscience, Medical University of South Carolina, Charleston, SC, United States, 2Center for Biomedical Imaging, Medical University of South Carolina, Charleston, SC, United States, 3Department of Neurology, Medical University of South Carolina, Charleston, SC, United States
Synopsis
The triple transgenic mouse model (3xTg) of Alzheimer’s disease (AD)
exhibits both Aβ and tau pathology. Although diffusion MRI (dMRI) is an
established tool for tracking changes in brain microstructure for aging and AD in
humans, prior research using diffusion tensor imaging has called into question
the sensitivity of dMRI for 3xTg mice. Here we investigated the sensitivity of
an alternative dMRI method, diffusional kurtosis imaging, to detect brain
changes associated with aging and disease progression in 3xTg mice. Our results
indicate that dMRI is able to capture age and/or pathology related alterations
in brain tissue for this mouse model.
INTRODUCTION:
This study uses diffusion MRI (dMRI) to examine AD-related pathology in aged
triple transgenic mice model of AD (3xTg), which exhibits both Aβ and tau
pathology1. This model has been well-characterized
morphologically and biochemically2,3, but only two dMRI studies
have been published4,5 to date. Although abnormal brain
myelination patterns have been described in young 3xTg mice6,
assessment of white matter (WM) in 3xTg mice using diffusion tensor imaging (DTI)
revealed no significant differences compared with age-matched controls4.
Recently, abnormalities in the hippocampus of 3xTg mice were detected using DTI5.
Diffusional kurtosis imaging (DKI) is a dMRI technique that quantifies the
non-Gaussian properties of water diffusion, contributing additional information
beyond that provided by DTI7. Our goal was to investigate the
sensitivity of DKI to capture brain microstructural alterations associated with
different stages of disease progression
(11-18 months old) in the 3xTg mouse model. METHODS:
Five female 3xTg mice were studied longitudinally at 11, 15 and 18
months of age. In vivo MRI
experiments were performed on a 7T Bruker MRI system (PARAVISION 5.1). A 2-shot
SE-EPI sequence was used for DKI acquisition. Sequence parameters:
TR/TE=3750/32.6ms, δ/Δ=5/18ms, slice thickness=0.7 mm, 15 slices with no gap,
data matrix=128×128, image resolution=156×156μm2, 2 signal acquisitions,
10 b-value=0 images, followed by 30 diffusion encoding gradient directions with
4 b-values for each gradient direction (0.5, 1, 1.5, 2 ms/μm2) and fat
suppression flip angle=105°. Total acquisition time=33 minutes. Mean (MD),
axial (D‖) and radial (D┴) diffusivity, fractional
anisotropy (FA), mean kurtosis (MK), axial (K‖) and radial (K┴)
kurtosis, were derived from the DKI data (Figure 1) set using Diffusional
Kurtosis Estimator software (DKE; http://www.nitrc.org/projects/dke)9.
Regions of interest (ROIs) at the level of the cortex (Ctx), dorsal (DH) and
ventral (VH) hippocampus, corpus callosum (CC), fimbria (Fi), external (EC) and
internal (IC) capsule were manually drawn in the average b-value=0 image, using
ImageJ (http://rsb.info.nih.gov/) (Figure 2). Two-tailed
paired t-tests were performed to assess differences in the ROI measurements
between the three age groups. The advantage of DKI relative to DTI is that DKI
provides estimates for both the diffusivity (MD,
D‖, D┴,
FA) and kurtosis (MK, K‖, K┴), metrics, while DTI only yields values for the
diffusivity metrics. In this way, DKI enables a more comprehensive assessment
of the diffusion microenvironment in brain tissue.RESULTS:
Table 1 shows all age-group means, standard
deviations and uncorrected p-values for all the diffusion metrics in each ROI. For
WM regions, diffusivity metrics show an overall trend to decrease with age. Even
after a Bonferroni correction (7 tests), MD is significantly reduced in the EC,
and D‖ is
significantly reduced in the CC, EC, IC in 18 months old mice (relative to 11
months). For kurtosis metrics, K‖ is significantly increased in the Fi in both
15 and 18 months old mice (relative to 11 months).
In grey matter (GM) regions, FA is significantly
reduced in the Ctx of 18 months old mice. The kurtosis metrics show an overall
trend to increase with age, with MK being significantly increased in the DH and
K‖ being significantly increased in the VH in 15
months old mice (relative to 11 months). Figure 2 & 3 shows the scatter
plots for all WM and GM results that survived Bonferroni correction,
respectively.
DISCUSSION & CONCLUSION:
Our results show that
dMRI is able to capture age and/or pathology related brain changes in the 3xTg
mouse model. As we did not include a control group in this preliminary study, it
is not possible to determine the extent to which the observed dMRI changes are related
to different stages of disease progression rather than to aging. However, since
3xTg mice are known to have moderate to intense Aβ and tau pathology in this
age range (11-18 months), our hypothesis is that Aβ deposition creates a more
heterogeneous brain microstructure, leading to an increase in kurtosis metrics,
as reported previously in the GM of the PS/APP AD mouse model9,10.
The decrease of diffusivity and increase of kurtosis metrics in WM & GM regions
with age may be related to morphological changes previously described in this
model, such as myelin abnormalities5, tau-related axon pathology1
and inflammation2, which would lead to increased barriers for
diffusion. This study is the first application of DKI to 3xTg mice, and it illustrates
the enhanced sensitivity, in comparison to DTI, for detecting alterations in
brain microstructure provided by the addition of the kurtosis metrics.Acknowledgements
This study was supported, in part, by NIH grant R01AG057602-01References
1. Oddo S, et al. (2003)
Neuron, 39(3): 409-421. 2. Oddo S, et al.
(2003) Neurobiol Aging, 24(8):1063-70. 3.
Oh KJ, et al. (2010) Int J Alzheimers Dis, Article ID 780102. 4. Kastyak-Ibrahimet MZ, et al. (2013) Magn
Reson Imaging. 31(9):1515-21. 5. Snow WM,
et al. (2017) J Alzheimers Dis, 58(3):841-853.
6. Desai MK, et al. (2009) Glia, 57(1):54-65. 7. Jensen JH, et al. (2005) Magn Reson Med,
53:1432-1440. 8. Tabesh A, et al. (2011)
Magn Reson Med, 65(3):823-36. 9. Falangola MF, et al. (2007) 15th Scientific
Meeting of the ISMRM, Berlin, Germany, pp. 310. 10. Vanhoutte, G, et al. (2013)
Magn Reson Med, 69(4) 1115-1121.